Cong Xu
Private Equity Investor chez LAV Management Co., Ltd.
Profil
Cong Xu is currently the Managing Director at LAV Management Co., Ltd.
He previously worked as the Vice President at IMPACT Therapeutics, Inc. from 2018 to 2019.
Mr. Xu graduated from Clemson University in 2012 with a graduate degree and obtained an MBA from the University of British Columbia in 2018.
Postes actifs de Cong Xu
| Sociétés | Poste | Début |
|---|---|---|
LAV Management Co., Ltd.
 LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Private Equity Investor | 01/01/2018 |
Anciens postes connus de Cong Xu
| Sociétés | Poste | Fin |
|---|---|---|
IMPACT Therapeutics, Inc.
 IMPACT Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology IMPACT Therapeutics, Inc. manufactures pharmaceutical products. The firm develops discovery and commercialization of novel therapeutics to treat cancer and other life-threatening diseases. The company was founded in 2009 and is headquartered in Nanjing, China. | President | 01/12/2019 |
Formation de Cong Xu
| University of British Columbia | Masters Business Admin |
| Clemson University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Finance |
IMPACT Therapeutics, Inc.
IMPACT Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology IMPACT Therapeutics, Inc. manufactures pharmaceutical products. The firm develops discovery and commercialization of novel therapeutics to treat cancer and other life-threatening diseases. The company was founded in 2009 and is headquartered in Nanjing, China. | Health Technology |
